{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:10:56Z","timestamp":1788923456554,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.acuroe.2023.02.002","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T02:21:25Z","timestamp":1675650085000},"page":"408-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Urinary pH and antibiotics, choose carefully. A systematic review"],"prefix":"10.1016","volume":"47","author":[{"given":"G.","family":"Ordaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Dag\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Budia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"P\u00e9rez-Lanzac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Jord\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.acuroe.2023.02.002_bib0005","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.urology.2014.04.048","article-title":"The influence of urinary pH on antibiotic efficacy against bacterial uropathogens","volume":"84","author":"Yang","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.acuroe.2023.02.002_bib0010","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/AAC.02147-13","article-title":"Urinary concentrations and antibacterial activities of nitroxoline at 250 miligrams versus trimethoprim at 200 milligrams against uropathogens in healthy volunteers","volume":"58","author":"Wagenlehner","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.acuroe.2023.02.002_bib0015","doi-asserted-by":"crossref","DOI":"10.1177\/1756287219832172","article-title":"An introduction to the epidemiology and burden of urinary tract infections","volume":"11","author":"Medina","year":"2019","journal-title":"Ther Adv Urol."},{"key":"10.1016\/j.acuroe.2023.02.002_bib0020","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles","year":"2015","journal-title":"Nat Rev Microbiol"},{"issue":"Suppl 1","key":"10.1016\/j.acuroe.2023.02.002_bib0025","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/318850","article-title":"Urinary tract infections: disease panorama and challenges","volume":"183","author":"Stamm","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.acuroe.2023.02.002_bib0030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0891-5520(03)00005-9","article-title":"Epidemiology of urinary tract infections \u2013 transmission and risk factors, incidence and costs","volume":"17","author":"Foxman","year":"2003","journal-title":"Infect Dis Clin North Am"},{"issue":"4","key":"10.1016\/j.acuroe.2023.02.002_bib0035","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10096-016-2577-0","article-title":"An infectious disease and pharmacokinetic perspective on oral antibiotic treatment of uncomplicated urinary tract infections due to multidrug-resistant Gram-negative uropathogens: the importance of urinary antibiotic concentrations and urinary pH","volume":"35","author":"Cunha","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis."},{"issue":"5","key":"10.1016\/j.acuroe.2023.02.002_bib0040","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/am.20.5.754-756.1970","article-title":"Effect of pH on the activity of erythromycin against 500 isolates of gram-negative bacilli","volume":"20","author":"Lorian","year":"1970","journal-title":"Appl Microbiol."},{"key":"10.1016\/j.acuroe.2023.02.002_bib0045","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0022-5347(17)63620-6","article-title":"Ascorbic acid as urinary acidifying agent: 2. Its adjunctive role in chronic urinary infection","volume":"94","author":"Murphy","year":"1965","journal-title":"J Urol"},{"issue":"Suppl2","key":"10.1016\/j.acuroe.2023.02.002_bib0050","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1007\/BF01643429","article-title":"Fosfomycin trometamol: activity in vitro against urinary tract pathogens","volume":"18","author":"Greenwood","year":"1990","journal-title":"Infection"},{"key":"10.1016\/j.acuroe.2023.02.002_bib0055","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.resmic.2011.01.004","article-title":"Impact of pH on bacterial growth and activity of recent fluoroquinolones in pooled urine","volume":"162","author":"Erdogan-Yildrim","year":"2011","journal-title":"Res Microbiol"},{"key":"10.1016\/j.acuroe.2023.02.002_bib0060","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000342423","article-title":"Impact of pH on activity of trimethoprim, fosfomycin, amikacin, colistin and ertapenem in human urine","volume":"90","author":"Burian","year":"2012","journal-title":"Pharmacology"},{"key":"10.1016\/j.acuroe.2023.02.002_bib0065","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/jama.1961.03040130016004","article-title":"The renal transport of nitrofurantoin","volume":"175","author":"Woodruff","year":"1961","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.acuroe.2023.02.002_bib0070","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1139\/W07-097","article-title":"Fluoroquinolone resistance of Serratia marcescens: sucrose, salicylate, temperature, and pH induction of phenotypic resistance","volume":"53","author":"Begic","year":"2007","journal-title":"Can J Microbiol."},{"key":"10.1016\/j.acuroe.2023.02.002_bib0075","series-title":"Management of suspected bacterial urinary tract infection in adults. Scottish Intercollegiate Guidelines Network","first-page":"88","author":"SIGN","year":"2012"},{"key":"10.1016\/j.acuroe.2023.02.002_bib0085","unstructured":"Bonkat G., Bartoletti R.R., Bruy\u00e8re F. et al. EAU guidelines 2019; Urological Infections: 12."},{"issue":"7","key":"10.1016\/j.acuroe.2023.02.002_bib0090","first-page":"142","article-title":"Should nitrofurantoin be used to treat alkaline urinary tract infection?","volume":"50","author":"Sheele","year":"2018","journal-title":"E Med"},{"key":"10.1016\/j.acuroe.2023.02.002_bib0095","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s004670000493","article-title":"Recurrence and follow-up after urinary tract infection under the age of 1 year","volume":"16","author":"Nuutinen","year":"2001","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"10.1016\/j.acuroe.2023.02.002_bib0100","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1073\/pnas.73.9.3293","article-title":"Suppression of lytic effect of beta lactams on Escherichia coli and other bacteria","volume":"73","author":"Goodell","year":"1976","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"10.1016\/j.acuroe.2023.02.002_bib0105","first-page":"335","article-title":"Influence of pH and human urine on the antibacterial activity of ciprofloxacin, norfloxacin and ofloxacin","volume":"11","author":"Zeiler","year":"1985","journal-title":"Drugs Exp Clin Res."},{"key":"10.1016\/j.acuroe.2023.02.002_bib0110","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000238584","article-title":"Conditions affecting the results of susceptibility testing for the quinolone compounds","volume":"34","author":"Smith","year":"1988","journal-title":"Chemother"},{"key":"10.1016\/j.acuroe.2023.02.002_bib0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejps.2012.04.022","article-title":"Predicting the exposure and antibacterial activity of fluoroquinolones based on physicochemical properties","volume":"47","author":"V\u00f6lgyi","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.acuroe.2023.02.002_bib0120","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1021\/jm700967e","article-title":"Physicochemical properties of antibacterial compounds: implications for drug discovery","volume":"51","author":"O\u2019Shea","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.acuroe.2023.02.002_bib0125","doi-asserted-by":"crossref","first-page":"e02446","DOI":"10.1128\/AAC.02446-16","article-title":"Pharmacodynamics of finafloxacin, ciprofloxacin and levofloxacin in serum and urine against TEM- and SHV-type extended-spectrum-\u03b2-lactamase-producing enterobacteriaceae isolates from patients with urinary tract infections","volume":"61","author":"Dalhoff","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.acuroe.2023.02.002_bib0130","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1128\/AAC.00833-10","article-title":"In vitro spectrum of activity of finafloxacin, a novel pH-activated fluoroquinolone, under standard and acidic conditions","volume":"55","author":"Stubbings","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.acuroe.2023.02.002_bib0135","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000321028","article-title":"Urinary pharmacokinetics and bactericidal activity of finafloxacin (200 and 800 mg) in healthy volunteers receiving a single oral dose","volume":"57","author":"Wagenlehner","year":"2011","journal-title":"Chemotherapy"},{"key":"10.1016\/j.acuroe.2023.02.002_bib0140","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1128\/AAC.00886-10","article-title":"Comparative in vitro activities of the novel antibacterial finafloxacin agains selected gram-positive and gram-negative bacteria tested in Mueller-Hinton broth and synthetic urine","volume":"55","author":"Dalhoff","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.acuroe.2023.02.002_bib0145","unstructured":"Wagenlehner F., Nowicki M., Bentley C. et al. Safety and efficacy of finafloxacin versus ciprofloxacin in the treatment of hospitalized patients with complicated urinary tract infections and pyelonephritis determined in a phase 2 clinical study, abstr L-1251. 55th Intersci Conf Antimicrob Agents Chemother, San Diego CA."},{"key":"10.1016\/j.acuroe.2023.02.002_bib0150","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1128\/AAC.00602-16","article-title":"Urinary tract physiological conditions promote ciprofloxacin resistance in low-level-quinolone-resistant Escherichia coli","volume":"60","author":"Martin-Guti\u00e9rrez","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.acuroe.2023.02.002_bib0155","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.juro.2015.01.094","article-title":"Effects of urinary matrix and pH on the potency of delafloxacin and ciprofloxacin against urogenic Escherichia coli and Klebsiella pneumoniae","volume":"194","author":"So","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2023.02.002_bib0160","doi-asserted-by":"crossref","first-page":"e02615","DOI":"10.1128\/AAC.02615-16","article-title":"Plasmidic qnr genes confer clinical resistance to ciprofloxacin under urinary tract physiological conditions","volume":"61","author":"Martin-Guti\u00e9rrez","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.acuroe.2023.02.002_bib0165","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1128\/jb.157.3.863-867.1984","article-title":"Quantitative association between electrical potential across the cytoplasmic membrane and early gentamicin uptake and killing in Staphylococcus aureus","volume":"157","author":"Eisenberg","year":"1984","journal-title":"J Bacteril"},{"issue":"3","key":"10.1016\/j.acuroe.2023.02.002_bib0170","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijantimicag.2017.11.004","article-title":"Urinary concentrations and antimicrobial activity of tobramycin in healthy volunteers receiving a single oral dose of a novel formulation for improved absorption","volume":"51","author":"Loose","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.acuroe.2023.02.002_bib0175","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1007\/BF01643691","article-title":"MICs of ciprofloxacin and trimethoprim for Escherichia coli: influence of pH, inoculum size an various body fluids","volume":"19","author":"Aagaard","year":"1991","journal-title":"Infection"},{"issue":"7","key":"10.1016\/j.acuroe.2023.02.002_bib0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200272","article-title":"pH plays a role in the mode of action of trimethoprim on Escherichia coli","volume":"13","author":"AlRabiah","year":"2018","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.acuroe.2023.02.002_bib0185","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1159\/000472869","article-title":"Effect of fosfomycin trometamol on bacterial adhesion in comparison with other chemotherapeutic agents","volume":"13","author":"Carlone","year":"1987","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2023.02.002_bib0190","doi-asserted-by":"crossref","first-page":"e02498","DOI":"10.1128\/AAC.02498-16","article-title":"Pharmacodynamic evaluation of fosfomycin against Escherichia coli and Klebsiella spp from urinary tract infections and the influence of pH on fosfomycin activities","volume":"61","author":"Fedrigo","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.acuroe.2023.02.002_bib0195","doi-asserted-by":"crossref","first-page":"e01899","DOI":"10.1128\/AAC.01899-17","article-title":"Urinary tract conditions affect fosfomycin activity against Escherichia coli strains harbouring chromosomal mutations involved in fosfomycin uptake","volume":"62","author":"Martin-Guti\u00e9rrez","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.acuroe.2023.02.002_bib0200","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/jac\/dkv147","article-title":"Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials","volume":"70","author":"Huttner","year":"2015","journal-title":"J Antimicrob Chemother"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578623000112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578623000112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:16:45Z","timestamp":1761880605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173578623000112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2173578623000112"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2023.02.002","relation":{},"ISSN":["2173-5786"],"issn-type":[{"value":"2173-5786","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary pH and antibiotics, choose carefully. A systematic review","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2023.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2022.12.008","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}